Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis

BACKGROUND AND AIM: Given the paucity of evidence-based treatment recommendations, the most appropriate first-line regimen for adult Burkitt lymphoma is currently undefined. We aimed to identify the optimal treatment regimen containing rituximab for adult Burkitt lymphoma patients. METHODS: The PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xiaoxuan, Liu, Yu, Liu, Ruyu, Liu, Jiaxin, Yan, Xiaojing, Qian, Liren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816660/
https://www.ncbi.nlm.nih.gov/pubmed/36620579
http://dx.doi.org/10.3389/fonc.2022.1063689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816660/
https://www.ncbi.nlm.nih.gov/pubmed/36620579
http://dx.doi.org/10.3389/fonc.2022.1063689

Ejemplares similares